Study of Fast Discharge Within 24 Hours Versus Standard Care After Acute Myocardial Infarction with Invasive Treatment A Randomized Multicenter Trial Evaluating Safety and Cardiovascular Outcomes

What this Trial Is About

Researchers are evaluating whether a faster hospital discharge after invasive treatment for acute myocardial infarction heart attack is as safe as the standard longer stay. This trial compares a fast discharge strategy, where patients leave the hospital about 24 hours after treatment, to the usual care of staying more than 36 hours. The study aims to find out if early discharge increases the risk of major heart-related problems over a year following the heart attack. Participants are randomly assigned to one of two groups one group receives standard care with discharge after more than 36 hours, while the other group is discharged early at around 24 hours following invasive management. This approach includes patients who had successful procedures to open blocked heart arteries. The trial is conducted at multiple centers and monitors patients for up to 12 months after randomization. During the study, participants will be regularly assessed for major adverse cardiovascular events such as heart attacks, strokes, hospital readmissions, bleeding events, and death from any cause. Researchers will also measure hospital stay length, healthcare costs, and treatment adherence. Follow-up includes monitoring these outcomes up to 12 months after the initial treatment to evaluate the safety and impact of the faster discharge plan.

Fast Discharge After Acute Myocardial Infarction Discharge MI